The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asano, Y.
Right arrow Articles by Tamaki, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asano, Y.
Right arrow Articles by Tamaki, K.
The Journal of Immunology, 2004, 172: 7123-7135.
Copyright © 2004 by The American Association of Immunologists

Phosphatidylinositol 3-Kinase Is Involved in {alpha}2(I) Collagen Gene Expression in Normal and Scleroderma Fibroblasts1

Yoshihide Asano, Hironobu Ihn2, Kenichi Yamane, Masatoshi Jinnin, Yoshihiro Mimura and Kunihiko Tamaki

Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan

TGF-{beta} is implicated in the pathogenesis of fibrotic disorders. It has been shown that Smad3 promotes the human {alpha}2(I) collagen (COL1A2) gene expression by TGF-{beta}1 in human dermal fibroblasts. Here, we investigated the role of phosphatidylinositol 3-kinase (PI3K) in the COL1A2 gene expression in normal and scleroderma fibroblasts. In normal fibroblasts, the PI3K inhibitor, LY294002, significantly decreased the basal and the TGF-{beta}1-induced increased stability of COL1A2 mRNA. The TGF-{beta}1-induced COL1A2 promoter activity, but not the basal activity, was significantly attenuated by LY294002 or the dominant negative mutant of p85 subunit of PI3K, while the constitutive active mutant of p110 subunit of PI3K did not affect the basal or the TGF-{beta}1-induced COL1A2 promoter activity. LY294002 significantly decreased the phosphorylation of Smad3 induced by TGF-{beta}1. Furthermore, the transient overexpression of 2xFYVE, which induces the mislocalization of FYVE domain proteins, decreased the TGF-{beta}1-induced Smad3 phosphorylation to a similar extent to LY294002. In scleroderma fibroblasts, the blockade of PI3K significantly decreased the mRNA stability and the promoter activity of the COL1A2 gene. Furthermore, LY294002 and the transient overexpression of 2xFYVE completely diminished the constitutive phosphorylation of Smad3. These results indicate that 1) the basal activity of PI3K is necessary for the COL1A2 mRNA stabilization in normal and scleroderma fibroblasts, 2) there is an unidentified FYVE domain protein specifically interacting with Smad3, and 3) the basal activity of PI3K and the FYVE domain protein are indispensable for the efficient TGF-{beta}/Smad3 signaling in normal fibroblasts and for the establishment of the constitutive activation of TGF-{beta}/Smad3 signaling in scleroderma fibroblasts.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
Y. Asano and M. Trojanowska
Phosphorylation of Fli1 at Threonine 312 by Protein Kinase C {delta} Promotes Its Interaction with p300/CREB-Binding Protein-Associated Factor and Subsequent Acetylation in Response to Transforming Growth Factor {beta}
Mol. Cell. Biol., April 1, 2009; 29(7): 1882 - 1894.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
E. L. Axe, S. A. Walker, M. Manifava, P. Chandra, H. L. Roderick, A. Habermann, G. Griffiths, and N. T. Ktistakis
Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum
J. Cell Biol., August 26, 2008; 182(4): 685 - 701.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P.-P. Kuang, X.-H. Zhang, C. B. Rich, J. A. Foster, M. Subramanian, and R. H. Goldstein
Activation of elastin transcription by transforming growth factor-beta in human lung fibroblasts
Am J Physiol Lung Cell Mol Physiol, April 1, 2007; 292(4): L944 - L952.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
Y. Asano, H. Ihn, M. Kubo, M. Jinnin, Y. Mimura, R. Ashida, and K. Tamaki
Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis
Rheumatology, March 1, 2006; 45(3): 303 - 307.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Q. Xiao, C. G. Freire-de-Lima, W. J. Janssen, K. Morimoto, D. Lyu, D. L. Bratton, and P. M. Henson
Oxidants Selectively Reverse TGF-{beta} Suppression of Proinflammatory Mediator Production
J. Immunol., January 15, 2006; 176(2): 1209 - 1217.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Asano, H. Ihn, K. Yamane, M. Jinnin, Y. Mimura, and K. Tamaki
Increased Expression of Integrin {alpha}v{beta}3 Contributes to the Establishment of Autocrine TGF-{beta} Signaling in Scleroderma Fibroblasts
J. Immunol., December 1, 2005; 175(11): 7708 - 7718.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Laplante, M.-A. Raymond, G. Gagnon, N. Vigneault, A. M.-J. Sasseville, Y. Langelier, M. Bernard, Y. Raymond, and M.-J. Hebert
Novel Fibrogenic Pathways Are Activated in Response to Endothelial Apoptosis: Implications in the Pathophysiology of Systemic Sclerosis
J. Immunol., May 1, 2005; 174(9): 5740 - 5749.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Mimura, H. Ihn, M. Jinnin, Y. Asano, K. Yamane, and K. Tamaki
Constitutive Thrombospondin-1 Overexpression Contributes to Autocrine Transforming Growth Factor-{beta} Signaling in Cultured Scleroderma Fibroblasts
Am. J. Pathol., May 1, 2005; 166(5): 1451 - 1463.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Jinnin, H. Ihn, K. Yamane, Y. Mimura, Y. Asano, and K. Tamaki
{alpha}2(I) collagen gene regulation by protein kinase C signaling in human dermal fibroblasts
Nucleic Acids Res., March 1, 2005; 33(4): 1337 - 1351.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.